Citigroup Global Markets Holdings Inc., a subsidiary of Citigroup Inc., has issued a Free Writing Prospectus related to Contingent Income Auto-Callable Securities due November 2027, which are based on the performance of QUALCOMM Incorporated's common stock. The securities, with principal at risk, were detailed in a registration statement filed on November 8, 2024. The securities will pay a contingent coupon if the closing price of QUALCOMM's shares is above a certain threshold on predetermined valuation dates. The securities are set to mature on November 18, 2027, unless automatically redeemed earlier based on the performance of the underlying shares. The issuer has outlined the payment structure at maturity, which depends on the final share price relative to the downside threshold price, set at...Show More

Citigroup Global Markets Holdings Inc., a subsidiary of Citigroup Inc., has issued a Free Writing Prospectus related to Contingent Income Auto-Callable Securities due November 2027, which are based on the performance of QUALCOMM Incorporated's common stock. The securities, with principal at risk, were detailed in a registration statement filed on November 8, 2024. The securities will pay a contingent coupon if the closing price of QUALCOMM's shares is above a certain threshold on predetermined valuation dates. The securities are set to mature on November 18, 2027, unless automatically redeemed earlier based on the performance of the underlying shares. The issuer has outlined the payment structure at maturity, which depends on the final share price relative to the downside threshold price, set at 70% of the initial share price. The securities may pay less than the principal amount if the final share price is below the downside threshold. Citigroup's estimated value of the securities at issuance is $918.50 per security, which is below the public offering price. The offering is subject to Citigroup's credit risk, and the securities will not be listed on any securities exchange, potentially affecting their liquidity. Investors are advised to read the accompanying documents, including the preliminary pricing supplement, product supplement, prospectus supplement, and prospectus, as well as the detailed risk considerations before investing.